| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Celgene | 13.0% | -0.4% | -2.6% | -2.8% | 1.1% | 1.9% | 14.6% | 17.0% |
| Alexion | 12.8% | 0.0% | -4.8% | -3.8% | 2.2% | 7.2% | 14.7% | 15.9% |
| ONO | 10.2% | 0.1% | -7.0% | -4.2% | 10.8% | 0.1% | 21.3% | 22.2% |
| Regeneron | 9.6% | 0.2% | -1.4% | -2.6% | 2.4% | -12.5% | 14.5% | 13.2% |
| Chugai | 8.3% | 0.7% | -5.7% | -3.3% | 12.9% | 3.3% | 22.5% | 22.5% |
| AbbVie | 7.8% | 0.1% | -4.1% | -3.4% | 3.3% | -7.6% | 14.1% | 15.6% |
| Fresenius | 7.0% | 0.7% | -1.7% | 0.1% | 3.3% | 0.5% | 13.1% | 12.8% |
| Astra | 6.3% | 0.0% | -3.6% | -4.4% | 8.5% | 5.5% | 8.5% | 8.8% |
| FMC | 6.3% | -1.3% | -3.4% | 3.8% | 3.3% | 3.2% | 11.6% | 11.4% |
| Otsuka | 5.4% | 0.7% | -2.9% | 0.4% | 10.7% | | 8.6% | 8.6% |
| Bristol | 5.3% | -0.6% | -5.5% | -1.1% | 3.8% | -2.0% | 9.3% | 10.2% |
| Novo | 4.6% | -0.2% | -0.8% | 0.1% | -0.5% | -0.6% | 4.5% | 6.6% |
| Biogen | 4.1% | -0.1% | -0.8% | -3.0% | 0.1% | -2.7% | 5.3% | 6.3% |
| Novartis | 4.0% | 0.1% | -1.5% | -1.1% | 3.1% | 0.6% | 6.5% | 7.7% |
| JnJ | 3.8% | 0.3% | -2.0% | -1.2% | 3.1% | -0.3% | 6.1% | 7.8% |
| Mylan | 3.7% | 0.6% | -2.0% | 0.9% | 2.2% | 0.3% | 7.5% | 8.9% |
| Shire | 3.6% | 0.2% | -1.7% | -1.2% | 1.2% | 1.7% | 6.6% | 6.6% |
| Lilly | 3.4% | -0.1% | -3.4% | -2.4% | 5.2% | -3.0% | 10.1% | 10.7% |
| Sanofi | 3.0% | 0.2% | -1.2% | -0.1% | 1.7% | -1.6% | 4.0% | 4.8% |
| Roche | 2.9% | -0.1% | -0.4% | -0.1% | 0.0% | -3.8% | 4.6% | 5.0% |
| Takeda | 2.8% | 0.8% | | -1.7% | 6.4% | 4.6% | 8.8% | 8.8% |
| Bayer | 2.7% | 0.3% | -3.6% | -1.7% | 2.3% | -6.6% | 5.9% | 5.9% |
| Allergan | 2.6% | -0.1% | -1.3% | -1.0% | 0.8% | 1.8% | 4.9% | 5.7% |
| Glaxo | 2.6% | -0.1% | -1.1% | -0.1% | 0.9% | -1.4% | 4.3% | 4.0% |
| Merck | 2.5% | 0.0% | -1.9% | 0.1% | 1.7% | -0.6% | 4.2% | 6.0% |
| Merck KG | 2.3% | 0.1% | 0.0% | -1.1% | 3.5% | | 3.8% | 4.3% |
| Eisai | 2.3% | -1.4% | -1.4% | -1.0% | -1.9% | -1.2% | 0.6% | 0.6% |
| Pfizer | 2.2% | 0.0% | -1.9% | -1.4% | 1.6% | -3.2% | 4.5% | 6.1% |
| Daiichi | 1.6% | 0.8% | -0.1% | -2.0% | 9.2% | 0.8% | 10.7% | 11.4% |
| Astellas | 1.1% | 0.8% | 0.9% | 0.5% | 0.9% | 2.2% | 1.4% | 3.1% |
| Valeant | 1.0% | 0.3% | -0.8% | 3.5% | -0.1% | -0.4% | 8.6% | 8.0% |
| Lundbeck | 0.6% | 1.2% | -1.4% | 1.3% | 3.2% | -8.6% | 6.3% | 9.6% |
| Amgen | 0.4% | 0.0% | -2.2% | -0.4% | 0.8% | -4.1% | 2.0% | 4.7% |
| UCB | 0.1% | 0.6% | -0.3% | 0.8% | 0.1% | -0.4% | 2.8% | 0.6% |
| M Tanabe | -1.3% | -0.2% | 0.3% | 2.1% | -3.8% | 0.3% | -5.0% | -5.0% |
| Gilead | -3.2% | -0.2% | 3.9% | 6.2% | -3.1% | -2.4% | -4.9% | -3.0% |
| Teva | -3.8% | -1.2% | -1.7% | -5.5% | -0.2% | 3.7% | -2.6% | -4.0% |
| Shionogi | | | | | | | | |
| Other EU | 4.5% | -0.6% | -3.1% | -2.7% | 2.5% | 4.2% | 7.1% | 6.9% |
| EU Major | 3.6% | 0.0% | -1.3% | -0.8% | 1.7% | -1.4% | 5.4% | 6.1% |
| US Major | 3.9% | 0.1% | -2.7% | -1.4% | 2.9% | -2.6% | 7.2% | 9.9% |
| US Big Biotech | 3.7% | 0.1% | -0.5% | 0.6% | -0.3% | -3.2% | 4.6% | 9.0% |
| Other US | 0.3% | 0.1% | -1.3% | -1.4% | 1.1% | 1.6% | 3.8% | 5.4% |
| Japanese | 3.3% | 0.4% | -1.5% | -1.2% | 6.2% | 5.1% | 8.5% | 9.6% |